Onconova Therapeutics Inc. (ONTX)

Full-Year Financial Report Included Strong Pipeline Progress


Robert LeBoyerMedia Inquiries
Senior Life Sciences Analyst
March 21, 2022
Report ID: 24612
Get Report
Refer to the full report for the price target, fundamental analysis, and rating.

Equity Research provided by Noble Capital Markets is available at no cost to Registered users of Channelchek.

Already Registered? Click the ‘Get Report’ button to login and view the research report.

Not a Member? Click ‘Join’ or ‘Get Report’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.


Onconova Therapeutics Inc.
Onconova Therapeutics Inc.
Healthcare
Biotechnology
Ticker
ONTX
Current Price
$0.8528 3.54%
Market Cap
$17.8M
Price Target
Refer to Report
Volume
49.0K
52wk Range
$0.64805 - $3.0401
Related Research Reports
11/15/2022

Onconova Announces A New Trial With 3Q22 Results
Onconova Announces A New Trial With 3Q22 Results (ONTX)
9/13/2022

Rigosertib Phase 1/2a Trial Data Reported At ESMO
Rigosertib Phase 1/2a Trial Data Reported At ESMO (ONTX)
8/12/2022

All Trials Continue Toward Data Milestones
All Trials Continue Toward Data Milestones (ONTX)
5/12/2022

Clinical Trials Progressing As Expected As 1Q22 Reported
Clinical Trials Progressing As Expected As 1Q22 Reported (ONTX)

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy
© 2018-2022 Noble Financial Group, Inc. All Rights Reserved. Channelchek is provided at no cost to be used for information purposes only and not as investment advisement.